Differential risk of remission and ESRD in childhood FSGS

Pediatric Nephrology

Volumn 21, Issue 3, 2006, Pages 344-349

  Gipson, Debbie S ^a   Chin, Hyunsook ^a   Presler, Trevor P ^a   Jennette, Caroline ^a   Ferris, Maria E ^a   Massengill, Susan ^b   Gibson, Keisha ^a   Thomas, David B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

Author keywords

ESRD; Focal segmental glomerulosclerosis; Glomerular Disease Collaborative Network; Proteinuria

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; CALCINEURIN INHIBITOR; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; REMISSION; RISK ASSESSMENT; RISK REDUCTION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADOLESCENT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHILD; COHORT STUDIES; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY FAILURE, CHRONIC; NEPHROTIC SYNDROME; PROGNOSIS; PROTEINURIA; RECEPTORS, ANGIOTENSIN; REMISSION INDUCTION; RISK FACTORS;

EID: 33244498085     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-2097-0     Document Type: Article

References (30)

1. Mitsnefes M, Stablein D (2005) Hypertension in pediatric patients on long-term dialysis: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis 45:309-315
2. Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629-639
3. (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 98:561-564
4. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC (2005) Focal and segmental glomerulosclerosis: Definition and relevance of a partial remission. J Am Soc Nephrol 16:1061-1068
5. Cattran D (2005) Management of membranous nephropathy: When and what for treatment. J Am Soc Nephrol 15:1188-1194
6. Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG (1978) The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10:213-218
7. Velosa JA, Holley KE, Torres VE, Offord KP (1983) Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis. Mayo Clin Proc 58:568-577
8. Beaufils H, Alphonse JC, Guedon J, Legrain M (1978) Focal glomerulosclerosis: Natural history and treatment. A report of 70 cases. Nephron 21:75-85
9. Cattran DC, Rao P (1998) Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 32:72-79
10. Alexopoulos E, Stangou M, Papagianni A, Pantzaki A, Papadimitriou M (2000) Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis. Nephrol Dial Transplant 15:1348-1356
11. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC (2004) Pathologic classification of focal segmental glomerulosclerosis: A working proposal. Am J Kidney Dis 43:368-382
12. Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259-263
13. Schwartz GJ, Gauthier B (1985) A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 106:522-526
14. Schwartz GJ, Feld LG, Langford DJ (1984) A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr 104:849-854
15. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
16. Morales JV, Weber R, Wagner MB, Barros EJ (2004) Is morning urinary protein/creatinine ratio a reliable estimator of 24-hour proteinuria in patients with glomerulonephritis and different levels of renal function? J Nephrol 17:666-672
17. Watanabe M, Funabiki K, Tsuge T, Maeda K, Horikoshi S, Tomino Y (2005) Using protein/creatinine ratios in random urine. J Clin Lab Anal 19:160-166
18. Allison PD (1995) Competing risks. 6, Survival Analysis using the SAS system: A practical guide. SAS Publishing, Cary, NC, USA, pp 185-209
19. Collett D (2003) Modelling survival data. Modelling survival data in medical research, 2nd edn. Chapman & Hall, London, pp 55-193
20. Kalbfleisch JD, Prentice RL (2002) The statistical analysis of failure time data, 2nd edn. Wiley, New York, p 462
21. Chun MJ, Korbet SM, Schwartz MM, Lewis EJ (2004) Focal segmental glomerulosclerosis in nephrotic adults: Presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 15:2169-2177
22. Bagga A, Mudigoudar BD, Hari P, Vasudev V (2004) Enalapril dosage in steroid-resistant nephrotic syndrome. Pediatr Nephrol 19:45-50
23. Ruggenenti P, Perna A, Remuzzi G (2001) ACE inhibitors to prevent end-stage renal disease: When to start aAd why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy. J Am Soc Nephrol 12:2832-2837
24. Chiurchiu C, Remuzzi G, Ruggenenti P (2005) Angiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: The data of the meta-analyses. J Am Soc Nephrol 16 [Suppl 1]:S58-S63 S58-S63
25. Heering P, Braun N, Mullejans R, Ivens K, Zauner I, Funfstuck R, Keller F, Kramer BK, Schollmeyer P, Risler T, Grabensee B (2004) Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. Am J Kidney Dis 43:10-18
26. Cattran D, Neogi T, Sharma R, McCarthy ET, Savin VJ (2003) Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis. J Am Soc Nephrol 14:448-453
27. Lieberman KV, Tejani A (1996) A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol 7:56-63
28. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F (2004) Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15:722-732
29. Orloff MS, Iyengar SK, Winkler CA, Goddard KA, Dart RA, Ahuja TS, Mokrzycki M, Briggs WA, Korbet SM, Kimmel PL, Simon EE, Trachtman H, Vlahov D, Michel DM, Berns JS, Smith MC, Schelling JR, Sedor JR, Kopp JB (2005) Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population. Physiol Genomics 21:212-221
30. Pollak MR (2002) Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic viewpoint. J Am Soc Nephrol 13:3016-3023